After 40, the markers that matter most for cardiovascular risk, metabolic health, and hormonal function are almost never on a standard panel. Here’s what to order, why it matters, and the optimal ranges that most lab reports won’t show you.
Cardiovascular disease, type 2 diabetes, and hormonal decline don’t announce themselves. They develop along trajectories that begin in the late 30s and early 40s — often quietly, often asymptomatically, often while standard annual bloodwork returns a clean bill of health.
The problem isn’t that men over 40 aren’t getting tested. It’s that the tests being ordered were designed to detect existing disease, not predict it. A standard lipid panel misses ApoB — the most accurate cardiovascular risk marker available. A standard metabolic panel misses fasting insulin — the earliest signal of insulin resistance, elevated years before HbA1c moves. And hormone panels, when ordered at all, typically measure only total testosterone — which can look completely normal while free testosterone has declined to a functionally deficient level.
The markers below are the ones that change the picture for men over 40 specifically — organized by the clinical domain where standard care falls shortest.
Heart disease is the leading cause of death in men over 40. The standard annual lipid panel — LDL-C, HDL-C, triglycerides, total cholesterol — is a starting point, not a complete cardiovascular risk assessment. Two markers in particular are missing from most standard panels that fundamentally change what you can see.
| Marker | What it reveals | Optimal range | Standard care? |
|---|---|---|---|
| ApoB | Total count of atherogenic (plaque-forming) lipoprotein particles. More predictive of cardiovascular events than LDL-C because it counts particles, not cholesterol mass. A man can have “normal” LDL and elevated ApoB simultaneously. | <90 mg/dL | Skipped |
| Lp(a) | A genetically inherited lipoprotein that standard panels never measure. Elevated in roughly 1 in 5 people. It doesn’t respond to statins or diet. You can’t manage risk you don’t know about. Order once — it doesn’t change. | <30 mg/dL | Skipped |
| hsCRP | Predicts cardiovascular events independently of cholesterol. The high-sensitivity version (hsCRP) is required — standard CRP is too insensitive for cardiovascular risk stratification. Chronically elevated above 1.0 mg/L is a meaningful warning signal. | <1.0 mg/L | Skipped |
| Homocysteine | Elevated homocysteine is an independent cardiovascular and cognitive risk factor, strongly associated with endothelial damage and stroke. Directly modifiable with B vitamins — but only if you know it’s elevated. | <10 μmol/L | Skipped |
| Lipid panel | LDL-C, HDL-C, triglycerides, total cholesterol. Standard care does include this — but interpret it alongside ApoB, not in isolation. | TG <100 · HDL >60 | Included |
| Omega-3 Index | EPA+DHA as a percentage of red blood cell fatty acids. One of the most directly modifiable cardiovascular risk markers — low omega-3 index is associated with increased risk of sudden cardiac death. Fish oil works; but only if your index is low. | >8% | Skipped |
LDL-C measures the cholesterol mass inside LDL particles. ApoB counts the particles themselves. A man with small, dense LDL particles can have a “normal” LDL-C while carrying a large number of atherogenic particles — a situation that ApoB detects and LDL-C misses entirely. This is one of the most well-documented gaps in standard cardiovascular risk assessment. See the full ApoB breakdown →
Insulin resistance is the metabolic substrate underlying type 2 diabetes, visceral fat accumulation, cardiovascular disease, and accelerated aging. It develops gradually over years. And its earliest available signal — elevated fasting insulin — is almost never ordered in standard primary care.
| Marker | What it reveals | Optimal range | Standard care? |
|---|---|---|---|
| Fasting Insulin | The single most important metabolic marker for men over 40. Rises years before HbA1c or fasting glucose. An insulin above 10 μIU/mL with a normal glucose is insulin resistance in progress — actionable, reversible, and invisible on a standard panel. | <6 μIU/mL | Skipped |
| HbA1c | 90-day glucose average. Standard care orders this for diabetics and prediabetics. For men over 40, it belongs on every annual panel — but use a longevity-optimal threshold (below 5.4%) rather than the standard prediabetes cutoff of 5.7%. | 4.8–5.4% | Partial |
| Uric Acid | Elevated uric acid is an early marker of metabolic dysfunction and insulin resistance, and independently associated with hypertension, kidney disease, and cardiovascular risk. Often elevated before formal metabolic syndrome develops. | <5.5 mg/dL | Skipped |
| ALT | Liver health and metabolic function. Elevated ALT in an otherwise “healthy” man often signals non-alcoholic fatty liver disease (NAFLD) — the hepatic manifestation of insulin resistance. Optimal range is tighter than standard lab flags. | <30 U/L (M) | Included* |
| GGT | A more sensitive liver marker than ALT alone. GGT rises with both metabolic liver stress and alcohol. Independently predicts cardiovascular mortality even at values within the standard “normal” range. | <20 U/L (M) | Skipped |
A fasting glucose of 88 mg/dL and an HbA1c of 5.4% look clean on a standard panel. But if fasting insulin is 14 μIU/mL, the pancreas is working overtime to maintain that normal glucose — a state that reliably progresses to overt insulin resistance over years. Fasting insulin is the only marker that reveals this, and it is almost never ordered.
When men over 40 ask about hormone testing, they usually mean testosterone. But a meaningful male hormone panel requires understanding the full axis — because total testosterone alone is frequently misleading. What matters is how much testosterone is biologically active, and what the rest of the hormonal system is doing.
Roughly 40–45% of total testosterone is tightly bound to SHBG (sex hormone-binding globulin) and biologically unavailable. As SHBG rises with age — which it does predictably and progressively — a larger fraction of total testosterone becomes inactive. A man with 500 ng/dL total testosterone and high SHBG may have less bioavailable testosterone than a man with 380 ng/dL and low-normal SHBG. Free testosterone, not total, predicts functional outcomes in men over 40.
| Marker | What it reveals | Optimal range (men) | Standard care? |
|---|---|---|---|
| Total Testosterone | The baseline measurement. Necessary but insufficient on its own. Standard care flags below 300 ng/dL; the functional symptom threshold in men over 40 is closer to 400–450 ng/dL. | 500–900 ng/dL | Partial |
| Free Testosterone | The bioavailable fraction — the most clinically relevant number for men over 40. Low free testosterone predicts fatigue, muscle loss, cognitive decline, and metabolic deterioration even when total testosterone appears normal. | >70 pg/mL | Skipped |
| SHBG | The binding protein that determines how much testosterone is active. Rising SHBG is the primary mechanism of functional testosterone decline in men over 40. Also an independent metabolic marker — low SHBG correlates with insulin resistance and cardiovascular risk. | 20–40 nmol/L | Skipped |
| Estradiol (E2) | Men need estradiol for bone density, cardiovascular health, and libido — but elevated E2 from aromatase activity (which increases with body fat) suppresses testosterone production and drives symptoms. Always measure alongside testosterone. | 20–40 pg/mL | Skipped |
| DHEA-S | An adrenal precursor hormone that peaks in the mid-20s and declines steadily. Low DHEA-S correlates with accelerated biological aging, reduced immune function, and metabolic decline. Directly supplementable. | 200–400 μg/dL | Skipped |
| TSH + Free T3/T4 | Thyroid function affects testosterone metabolism, energy, cognition, and body composition. Subclinical hypothyroidism — TSH elevated above 2.0 with normal free T4 — is common and underdiagnosed. Standard care orders TSH alone; free T3 and T4 require a specific request. | TSH 1.0–2.0 mIU/L | Partial |
| IGF-1 | Growth hormone axis function. Declines with age. Low IGF-1 is associated with reduced muscle mass, poor recovery, and cognitive decline. The target range is middle-of-normal — not too low (anabolic deficiency) and not too high (accelerated aging). | 120–180 ng/mL | Skipped |
Prostate cancer is the second leading cause of cancer death in American men. The argument about PSA screening has largely focused on overdiagnosis in older men — but for men starting a baseline at 40, the primary value is establishing a reference point for tracking PSA velocity over time, not immediate diagnosis.
| Marker | What it reveals | Note | Standard care? |
|---|---|---|---|
| PSA | Prostate-specific antigen — a marker of prostate cell activity. A single value is less informative than trend. PSA doubling time under 2 years is clinically significant regardless of absolute value. Baseline at 40 enables velocity tracking over subsequent years. | Order once at 40 to establish baseline | Skipped (40s) |
Per American Urological Association guidelines, PSA should be measured in all men over 40 before starting testosterone replacement therapy. If you’re considering TRT, establish your PSA baseline first — both as a prostate cancer screen and to track any PSA changes after therapy begins.
These are not optional additions — they’re the markers most often responsible for the fatigue, cognitive fog, and poor recovery that men in their 40s attribute to “just getting older.” Deficiencies in Vitamin D and magnesium are among the most prevalent and most correctable problems in this demographic.
| Marker | What it reveals | Optimal range | Standard care? |
|---|---|---|---|
| Vitamin D (25-OH) | Deficiency is associated with cardiovascular disease, cancer, testosterone suppression, immune dysfunction, and all-cause mortality. Below 30 ng/mL is deficient by any standard. Longevity-optimal is 50–80 ng/mL. Most men are under 40. | 50–80 ng/mL | Skipped |
| Magnesium (RBC) | Magnesium is involved in over 300 enzymatic reactions including testosterone synthesis, insulin signaling, and cardiovascular function. Standard serum magnesium is a poor indicator of intracellular status — RBC magnesium is the meaningful test. Deficiency is extremely common. | 5.6–6.8 mg/dL (RBC) | Skipped |
| Vitamin B12 | Critical for neurological function and homocysteine metabolism. Deficiency causes cognitive symptoms that are frequently misattributed to stress or aging. Essential for anyone with elevated homocysteine. | 600–900 pg/mL | Skipped |
| Creatinine + eGFR | Kidney function baseline. Important to establish before starting any new supplement or medication protocol. eGFR trending downward over years is an early warning signal even within the normal range. | eGFR >90 | Included |
| Ferritin | Iron stores. Both deficiency (fatigue, poor recovery) and excess (oxidative stress, organ damage) are common in men over 40. Unlike women, men have no monthly iron loss mechanism — ferritin tends to accumulate with age. | 50–150 ng/mL | Skipped |
Taken together, the full men’s longevity panel for age 40+ covers five domains. On a first draw, order all of these:
| Domain | Order |
|---|---|
| Cardiovascular | ApoB · Lp(a) · Lipid panel · hsCRP · Homocysteine · Omega-3 Index |
| Metabolic | Fasting Insulin · HbA1c · Uric Acid · GGT · ALT/AST · CBC · CMP |
| Hormonal | Total + Free Testosterone · SHBG · Estradiol · DHEA-S · TSH + Free T3/T4 · IGF-1 |
| Prostate | PSA (baseline) |
| Nutrients / Organs | Vitamin D · Magnesium (RBC) · Vitamin B12 · Ferritin · Creatinine/eGFR |
This is a comprehensive first-draw panel — roughly 25–30 individual markers. After the baseline, annual retesting covers the cardiovascular and metabolic markers. Hormones can be retested every 6–12 months depending on whether you’re actively managing them. Lp(a) only needs to be ordered once.
Not available in New York, New Jersey, Rhode Island, or Hawaii via Ulta. See the full Ulta Lab Tests review for details on state restrictions, draw fees, and what the competition offers.
Upload or paste your labs and get a full longevity analysis in 60 seconds — every marker scored against optimal ranges, with actionable priorities.